Next Article in Journal
Endoplasmic Reticulum Stress in the Diabetic Kidney, the Good, the Bad and the Ugly
Next Article in Special Issue
Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease
Previous Article in Journal
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Previous Article in Special Issue
Patient-Specific iPSC-Derived RPE for Modeling of Retinal Diseases
Open AccessReview

Concise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem Cells

1
Department of Genetic Medicine and Development, University of Geneva Medical School and Geneva University Hospitals, 1 Rue Michel-Servet, CH-1211 Geneva, Switzerland
2
Department of Obstetrics and Gynecology, Cantonal Hospital of Fribourg, Chemin des Pensionnats 2-6, 1708 Fribourg, Switzerland
*
Authors to whom correspondence should be addressed.
Academic Editor: Michael J. Edel
J. Clin. Med. 2015, 4(4), 696-714; https://doi.org/10.3390/jcm4040696
Received: 9 February 2015 / Revised: 23 March 2015 / Accepted: 31 March 2015 / Published: 15 April 2015
(This article belongs to the Special Issue iPS Cells for Modelling and Treatment of Human Diseases)
Down syndrome (DS, trisomy 21), is the most common viable chromosomal disorder, with an incidence of 1 in 800 live births. Its phenotypic characteristics include intellectual impairment and several other developmental abnormalities, for the majority of which the pathogenetic mechanisms remain unknown. Several models have been used to investigate the mechanisms by which the extra copy of chromosome 21 leads to the DS phenotype. In the last five years, several laboratories have been successful in reprogramming patient cells carrying the trisomy 21 anomaly into induced pluripotent stem cells, i.e., T21-iPSCs. In this review, we summarize the different T21-iPSCs that have been generated with a particular interest in the technical procedures and the somatic cell types used for the reprogramming. View Full-Text
Keywords: induced pluripotent stem cells; Down syndrome; trisomy 21; T21-iPSCs; reprogramming; isogenic iPSCs induced pluripotent stem cells; Down syndrome; trisomy 21; T21-iPSCs; reprogramming; isogenic iPSCs
Show Figures

Figure 1

MDPI and ACS Style

Hibaoui, Y.; Feki, A. Concise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem Cells. J. Clin. Med. 2015, 4, 696-714.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop